SLI

SLI handeln
2.212,64 PKT -3,09 PKT -0,14 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0QZBF

ISIN CH0030252883


Analysen zu SLI-Werten

Datum Rating Analyst
07.04.05 Swiss Life Underperformer LB Rheinland-Pfalz
07.04.05 Lonza Reduce Sarasin Research
08.04.05 Helvetia Baloise Neutral Sal. Oppenheim
07.04.05 Swiss Life Sell Merck Finck & Co
07.04.05 Swiss Life Buy M.M. Warburg
08.04.05 Swiss Life Underperform Credit Suisse First Boston
06.04.05 Roche Buy Helvea
06.04.05 Helvetia Baloise Accumulate Helvea
06.04.05 Swiss Life Sell Merck Finck & Co
07.04.05 Swiss Life Neutral Sarasin Research
06.04.05 Swiss Life Accumulate Helvea
07.04.05 Swiss Life Overweight Lehman Brothers
06.04.05 Swiss Life Overweight JP Morgan
06.04.05 Zurich Insurance Outperform Goldman Sachs
05.04.05 Zurich Insurance Buy Sarasin Research
04.04.05 Givaudan Neutral Sarasin Research
04.04.05 Swiss Life Overweight JP Morgan
04.04.05 Helvetia Baloise Buy Sarasin Research
04.04.05 Swiss Life Neutral Sarasin Research
01.04.05 Swisscom Neutral Helvea
31.03.05 Swiss Life Overweight Lehman Brothers
01.04.05 Swiss Life Outperform HypoVereinsbank
30.03.05 Swisscom Neutral Sarasin Research
29.03.05 Roche Buy Sarasin Research
24.03.05 Roche Sector Outperform Vontobel
24.03.05 Swisscom Neutral Sarasin Research
22.03.05 UBS Buy Merrill Lynch
22.03.05 ABB (Asea Brown Boveri) Overweight JP Morgan
22.03.05 Roche Buy Sarasin Research
23.03.05 UBS Neutral Merrill Lynch
21.03.05 Holcim Neutral Sarasin Research
22.03.05 Swisscom Neutral Helvea
21.03.05 ABB (Asea Brown Boveri) Neutral Sarasin Research
22.03.05 Holcim Accumulate Helvea
22.03.05 Geberit Reduce Helvea
22.03.05 ABB (Asea Brown Boveri) Accumulate Helvea
21.03.05 Novartis Neutral Sarasin Research
21.03.05 Novartis Kaufen Helaba Trust
22.03.05 Novartis Accumulate Helvea
21.03.05 Geberit Market Outperform Vontobel